PH25944A - Combination dosage form for pre-menopausal women - Google Patents

Combination dosage form for pre-menopausal women

Info

Publication number: PH25944A
Authority: PH; Philippines
Prior art keywords: dosage form; days; combination; combination dosage; estradiol
Prior art date: 1986-07-15

Application number

PH35524A

Other languages

English (en)

Inventor

G Virginia Upton

Original Assignee

American Home Prod

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1986-07-15

Filing date

1987-07-10

Publication date

1991-12-19

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=25388101&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=PH25944(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

1987-07-10 Application filed by American Home Prod filed Critical American Home Prod

1991-12-19 Publication of PH25944A publication Critical patent/PH25944A/en

Links

239000002552 dosage form Substances 0.000 title abstract 6
VOXZDWNPVJITMN-ZBRFXRBCSA-N 17β-estradiol Chemical compound OC1=CC=C2[C@H]3CC[C@](C)([C@H](CC4)O)[C@@H]4[C@@H]3CCC2=C1 VOXZDWNPVJITMN-ZBRFXRBCSA-N 0.000 abstract 4
230000027758 ovulation cycle Effects 0.000 abstract 3
WWYNJERNGUHSAO-XUDSTZEESA-N (+)-Norgestrel Chemical compound O=C1CC[C@@H]2[C@H]3CC[C@](CC)([C@](CC4)(O)C#C)[C@@H]4[C@@H]3CCC2=C1 WWYNJERNGUHSAO-XUDSTZEESA-N 0.000 abstract 2
229960005309 estradiol Drugs 0.000 abstract 2
229960004400 levonorgestrel Drugs 0.000 abstract 2
BFPYWIDHMRZLRN-UHFFFAOYSA-N 17alpha-ethynyl estradiol Natural products OC1=CC=C2C3CCC(C)(C(CC4)(O)C#C)C4C3CCC2=C1 BFPYWIDHMRZLRN-UHFFFAOYSA-N 0.000 abstract 1
BFPYWIDHMRZLRN-SLHNCBLASA-N Ethinyl estradiol Chemical compound OC1=CC=C2[C@H]3CC[C@](C)([C@](CC4)(O)C#C)[C@@H]4[C@@H]3CCC2=C1 BFPYWIDHMRZLRN-SLHNCBLASA-N 0.000 abstract 1
229960004976 desogestrel Drugs 0.000 abstract 1
RPLCPCMSCLEKRS-BPIQYHPVSA-N desogestrel Chemical compound C1CC[C@@H]2[C@H]3C(=C)C[C@](CC)([C@](CC4)(O)C#C)[C@@H]4[C@@H]3CCC2=C1 RPLCPCMSCLEKRS-BPIQYHPVSA-N 0.000 abstract 1
239000000262 estrogen Substances 0.000 abstract 1
229940011871 estrogen Drugs 0.000 abstract 1
229960002568 ethinylestradiol Drugs 0.000 abstract 1
GCKFUYQCUCGESZ-BPIQYHPVSA-N etonogestrel Chemical compound O=C1CC[C@@H]2[C@H]3C(=C)C[C@](CC)([C@](CC4)(O)C#C)[C@@H]4[C@@H]3CCC2=C1 GCKFUYQCUCGESZ-BPIQYHPVSA-N 0.000 abstract 1
SIGSPDASOTUPFS-XUDSTZEESA-N gestodene Chemical compound O=C1CC[C@@H]2[C@H]3CC[C@](CC)([C@](C=C4)(O)C#C)[C@@H]4[C@@H]3CCC2=C1 SIGSPDASOTUPFS-XUDSTZEESA-N 0.000 abstract 1
229960005352 gestodene Drugs 0.000 abstract 1
230000003054 hormonal effect Effects 0.000 abstract 1
IMSSROKUHAOUJS-MJCUULBUSA-N mestranol Chemical compound C1C[C@]2(C)[C@@](C#C)(O)CC[C@H]2[C@@H]2CCC3=CC(OC)=CC=C3[C@H]21 IMSSROKUHAOUJS-MJCUULBUSA-N 0.000 abstract 1
229960001390 mestranol Drugs 0.000 abstract 1
238000000034 method Methods 0.000 abstract 1
229940053934 norethindrone Drugs 0.000 abstract 1
VIKNJXKGJWUCNN-XGXHKTLJSA-N norethisterone Chemical compound O=C1CC[C@@H]2[C@H]3CC[C@](C)([C@](CC4)(O)C#C)[C@@H]4[C@@H]3CCC2=C1 VIKNJXKGJWUCNN-XGXHKTLJSA-N 0.000 abstract 1
239000006187 pill Substances 0.000 abstract 1
239000000583 progesterone congener Substances 0.000 abstract 1
238000009256 replacement therapy Methods 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
- A61K31/567—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in position 17 alpha, e.g. mestranol, norethandrolone
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

Health & Medical Sciences (AREA)
General Health & Medical Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Chemical & Material Sciences (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Medicinal Chemistry (AREA)
Animal Behavior & Ethology (AREA)
Life Sciences & Earth Sciences (AREA)
Engineering & Computer Science (AREA)
Organic Chemistry (AREA)
Bioinformatics & Cheminformatics (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Epidemiology (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Reproductive Health (AREA)
Endocrinology (AREA)
Urology & Nephrology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicines Containing Plant Substances (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Steroid Compounds (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Medicinal Preparation (AREA)

PH35524A 1986-07-15 1987-07-10 Combination dosage form for pre-menopausal women PH25944A (en)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
US88597186A	1986-07-15	1986-07-15

Publications (1)

Publication Number	Publication Date
PH25944A true PH25944A (en)	1991-12-19

Family

ID=25388101

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
PH35524A PH25944A (en)	1986-07-15	1987-07-10	Combination dosage form for pre-menopausal women

Country Status (20)

Country	Link
EP (1)	EP0253607B2 (de)
JP (1)	JP2645510B2 (de)
KR (1)	KR960001371B1 (de)
AT (1)	ATE75401T1 (de)
AU (1)	AU597084B2 (de)
CY (1)	CY1725A (de)
DE (1)	DE3778599D1 (de)
DK (2)	DK174724B1 (de)
ES (1)	ES2033850T5 (de)
GB (1)	GB2192542B (de)
GR (1)	GR3004472T3 (de)
HK (1)	HK67393A (de)
IE (1)	IE61236B1 (de)
LU (1)	LU90634I2 (de)
NL (1)	NL300025I2 (de)
PH (1)	PH25944A (de)
PT (1)	PT85305B (de)
SG (1)	SG55093G (de)
WO (1)	WO1988000469A1 (de)
ZA (1)	ZA875010B (de)

Families Citing this family (61)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4816258A (en) *	1987-02-26	1989-03-28	Alza Corporation	Transdermal contraceptive formulations
CH674618A5 (de) *	1987-04-02	1990-06-29	Ciba Geigy Ag
ES2024010B3 (es) *	1987-07-06	1992-02-16	Akzo Nv	Unidad de dosis farmaceutica.
US5276022A (en) *	1987-09-24	1994-01-04	Jencap Research Ltd.	Hormone preparation and method
EP0559240B1 (de) *	1987-09-24	2001-12-05	Jencap Research Limited	Oestrogen und Progestin enthaltende Verhütungspackungen
DE3916112A1 (de) *	1989-05-16	1990-11-22	Schering Ag	Dihydrospirorenon als antiandrogen
US5043331A (en) *	1989-06-15	1991-08-27	Orion-Yhtyma Oy	Treatment of postmenopausal disorders
IE71203B1 (en) *	1990-12-13	1997-02-12	Akzo Nv	Low estrogen oral contraceptives
IE62665B1 (en) *	1990-12-17	1995-02-22	Akzo Nv	Contraceptive regimen
MX9301121A (es) *	1992-03-02	1993-09-01	Schering Ag	Metodo y equipo para la contracepcion oral y regulacion de la menstruacion con estrogeno/progestina/aniprogestina.
US7704983B1 (en)	1992-03-02	2010-04-27	Eastern Virginia Medical School	Antiprogestin method for reducing side effects associated with low dosage HRT and oral contraception
ES2123666T3 (es) *	1992-03-21	1999-01-16	Entec	Aplicacion de estriol para la preparacion de un sistema terapeutico transdermico para tratar la osteoporosis climaterica.
DE4227989A1 (de) *	1992-08-21	1994-06-09	Schering Ag	Mittel zur transdermalen Applikation enthaltend 3-Keto-desogestrel
US6407082B1 (en)	1996-09-13	2002-06-18	New Life Pharmaceuticals Inc.	Prevention of ovarian cancer by administration of a vitamin D compound
DE4344462C2 (de) *	1993-12-22	1996-02-01	Schering Ag	Zusammensetzung für die Empfängnisverhütung
DE4411585A1 (de) *	1994-03-30	1995-10-05	Schering Ag	Pharmazeutisches Kombinationspräparat zur hormonalen Kontrazeption
US5552394A (en) *	1994-07-22	1996-09-03	The Medical College Of Hampton Roads	Low dose oral contraceptives with less breakthrough bleeding and sustained efficacy
US5897539A (en) *	1995-09-28	1999-04-27	Schering Aktiengesellschaft	Hormone replacement therapy method and hormone dispenser
US5747480A (en) *	1996-05-08	1998-05-05	American Home Products Corporation	Oral contraceptive
WO1998004269A1 (en) *	1996-07-26	1998-02-05	American Home Products Corporation	Monophasic contraceptive method and kit comprising a combination of a progestin and estrogen
US5858405A (en) *	1996-07-26	1999-01-12	American Home Products Corporation	Oral contraceptive
US6451778B1 (en)	1996-07-26	2002-09-17	Wyeth	Oral contraceptive
US6479475B1 (en)	1996-07-26	2002-11-12	Wyeth	Oral contraceptive
US5888543A (en) *	1996-07-26	1999-03-30	American Home Products Corporation	Oral contraceptives
US6765002B2 (en)	2000-03-21	2004-07-20	Gustavo Rodriguez	Prevention of ovarian cancer by administration of products that induce transforming growth factor-β and/or apoptosis in the ovarian epithelium
US6034074A (en)	1996-09-13	2000-03-07	New Life Pharmaceuticals Inc.	Prevention of ovarian cancer by administration of a Vitamin D compound
US6028064A (en)	1996-09-13	2000-02-22	New Life Pharmaceuticals Inc.	Prevention of ovarian cancer by administration of progestin products
US6511970B1 (en)	1996-09-13	2003-01-28	New Life Pharmaceuticals Inc.	Prevention of ovarian cancer by administration of products that induce transforming growth factor-beta and/or apoptosis in the ovarian epithelium
WO2001030355A1 (fr)	1999-10-25	2001-05-03	Laboratoire Theramex	Medicament contraceptif a base d'un progestatif et d'un estrogene et son mode de preparation
FR2754179B1 (fr)	1996-10-08	1998-12-24	Theramex	Nouvelle composition hormononale et son utilisation
US5898032A (en)	1997-06-23	1999-04-27	Medical College Of Hampton Roads	Ultra low dose oral contraceptives with less menstrual bleeding and sustained efficacy
AU9028098A (en) *	1997-08-27	1999-03-16	Ortho Pharmaceutical Corporation	Combinations of endometrial sparing progestins and endometrial atrophizing progestins with estrogens, in oral contraception
US6787531B1 (en)	1999-08-31	2004-09-07	Schering Ag	Pharmaceutical composition for use as a contraceptive
US20020132801A1 (en) *	2001-01-11	2002-09-19	Schering Aktiengesellschaft	Drospirenone for hormone replacement therapy
FR2832065B1 (fr)	2001-11-13	2004-11-05	Besins Int Belgique	Composition pharmaceutique a base de progesterone micronisee son procede de preparation et ses utilisations
RU2351339C2 (ru)	2001-12-05	2009-04-10	Дюрамед Фармасьютикалс, Инк.	Оральные контрацептивы для предотвращения беременности и уменьшения предменструальной симптоматики
US7772219B2 (en)	2003-05-02	2010-08-10	Teva Women's Health, Inc.	Methods of hormonal treatment utilizing extended cycle contraceptive regimens
AU2004257772B2 (en)	2003-07-16	2009-12-17	Teva Women's Health, Inc.	Methods of hormonal treatment utilizing contraceptive regimens with continuous estrogen administration
JP2007511533A (ja)	2003-11-14	2007-05-10	ワーナー・チルコット・カンパニー・インコーポレーテッド	段階的エストロゲン避妊薬
EP1535618A1 (de)	2003-11-26	2005-06-01	Schering Aktiengesellschaft	Pharmazeutische Zubereitung zur kontinuierlichen hormonellen Behandlung über einen Zeitraum von über 21-28 Tage beinhaltend zwei Estrogen und/oder Progestin Zusammensetzungen
DE102004019743B4 (de)	2004-04-20	2008-11-27	Bayer Schering Pharma Aktiengesellschaft	Mehrphasenpräparat zur Kontrazeption auf der Basis eines natürlichen Estrogens
DE102004026679A1 (de)	2004-05-28	2005-12-15	Grünenthal GmbH	Hormonales Kontrazeptivum enthaltend eine Kombination aus Ethinylestradiol und Chlormadinonacetat
DE102004026670A1 (de)	2004-05-28	2005-12-15	Grünenthal GmbH	Hormonales Kontrazeptivum enthaltend eine Kombination aus Ethinylestradiol und Chlormadinonacetat
DE102004026671A1 (de)	2004-05-28	2005-12-15	Grünenthal GmbH	Darreichungsform zur hormonalen Kontrazeption
US20070111975A1 (en)	2004-10-07	2007-05-17	Duramed Pharmaceuticals, Inc.	Methods of Hormonal Treatment Utilizing Ascending-Dose Extended Cycle Regimens
EP2392332A1 (de)	2004-10-07	2011-12-07	Teva Women's Health, Inc.	Verfahren zur hormonellen Behandlung mittels Therapien mit Dosissteigerung und verlängertem Zyklus
UY29527A1 (es) *	2005-05-13	2006-12-29	Schering Ag	Composicinn farmaccutica que contienen gestrgenos y/o estrngenos y 5-metil - (6s) - tetrhidrofolato.
US8153616B2 (en)	2005-10-17	2012-04-10	Bayer Pharma Aktiengesellschaft	Combination preparation for oral contraception and oral therapy of dysfunctional uterine bleeding containing estradiol valerate and dienogest and method of using same
WO2007076144A2 (en)	2005-12-27	2007-07-05	Duramed Pharmaceuticals, Inc.	Conjugated estrogen compositions, applicators, kits, and methods of making and use thereof
US8617597B2 (en)	2006-07-06	2013-12-31	Bayer Intellectual Property Gmbh	Pharmaceutical composition containing a tetrahydrofolic acid
EP1930010A1 (de)	2006-10-20	2008-06-11	Bayer Schering Pharma Aktiengesellschaft	Verwendung von Estradiolvalerat oder 17ß-Estradiol in Kombination mit Dienogest zur oralen Therapie für den Erhalt und/oder die Steigerung der weiblichen Libido
TW200840595A (en) *	2006-12-12	2008-10-16	Organon Nv	Oral contraceptive spray
WO2008079245A2 (en) *	2006-12-20	2008-07-03	Duramed Pharmaceuticals, Inc.	Orally disintegrating solid dosage forms comprising progestin and methods of making and use thereof
EA201070715A1 (ru)	2007-12-20	2011-02-28	Тева Вимен'С Хелс, Инк.	Режимы дозирования, фармацевтические композиции и упаковки для экстренной контрацепции
WO2009112232A2 (en) *	2008-03-10	2009-09-17	Vladimir Hanes	New drospirenone/17beta-estradiol regimen, pharmaceutical combination product and kit for performing this regimen
EP2343964A4 (de)	2008-10-08	2012-11-07	Agile Therapeutics Inc	Transdermale freisetzung
CA2740005C (en)	2008-10-08	2016-11-01	Agile Therapeutics, Inc.	Transdermal delivery
CA2740002C (en)	2008-10-08	2016-11-01	Agile Therapeutics, Inc.	Transdermal delivery
WO2010111488A1 (en)	2009-03-27	2010-09-30	Agile Therapeutics, Inc.	Transdermal delivery
WO2016187269A1 (en) *	2015-05-18	2016-11-24	Agile Therapeutics, Inc.	Contraceptive compositions and methods for improved efficacy and modulation of side effects
EP3272333A1 (de)	2016-07-22	2018-01-24	Chemo Research, S.L.	Vaginale zubereitung enthaltend eine kombination von östrogen und vitamin d

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US3669502A (en) †	1971-01-05	1972-06-13	Simpson Timber Co	Pneumatic spreader stoker
US3836651A (en) *	1972-02-22	1974-09-17	Biolog Concepts Inc	Novel oral contraceptive combination
DE2310963A1 (de) †	1972-04-14	1974-09-05	Schering Ag	Methode zur kontrazeption durch verabfolgung von stufenkombinationspraeparaten
DE2365103C3 (de) †	1973-12-21	1980-08-28	Schering Ag, 1000 Berlin Und 4619 Bergkamen	V erwendung von Hormonen zur Kontrazeption
NL8001593A (nl) *	1980-03-18	1981-10-16	Akzo Nv	Meerfasisch combinatiepreparaat voor orale anticonceptie.
US4425339A (en) *	1981-04-09	1984-01-10	Syntex (U.S.A.) Inc.	Treatment of menopausal symptoms
US4826831A (en) *	1983-08-05	1989-05-02	Pre Jay Holdings Limited	Method of hormonal treatment for menopausal or post-menopausal disorders involving continuous administration of progestogens and estrogens
US4544554A (en) *	1983-09-26	1985-10-01	Ortho Pharmaceutical Corporation	Triphasic oral contraceptive
DE3347125A1 (de) *	1983-12-22	1985-07-11	Schering AG, 1000 Berlin und 4709 Bergkamen	Mehrstufenkombinationspraeparat und seine verwendung zur oralen kontrazeption
ZA87332B (en) †	1986-02-27	1987-08-26	Warner Lambert Co	Compositions containing fixed combinations

1987
- 1987-07-08 IE IE183387A patent/IE61236B1/en active Protection Beyond IP Right Term
- 1987-07-08 DK DK198703518A patent/DK174724B1/da not_active IP Right Cessation
- 1987-07-09 ZA ZA875010A patent/ZA875010B/xx unknown
- 1987-07-09 AU AU75379/87A patent/AU597084B2/en not_active Expired
- 1987-07-10 KR KR1019880700286A patent/KR960001371B1/ko not_active Expired - Lifetime
- 1987-07-10 PT PT85305A patent/PT85305B/pt unknown
- 1987-07-10 JP JP62504480A patent/JP2645510B2/ja not_active Expired - Lifetime
- 1987-07-10 WO PCT/US1987/001646 patent/WO1988000469A1/en not_active Ceased
- 1987-07-10 PH PH35524A patent/PH25944A/en unknown
- 1987-07-13 GB GB8716431A patent/GB2192542B/en not_active Expired - Lifetime
- 1987-07-13 AT AT87306174T patent/ATE75401T1/de active
- 1987-07-13 EP EP87306174A patent/EP0253607B2/de not_active Expired - Lifetime
- 1987-07-13 ES ES87306174T patent/ES2033850T5/es not_active Expired - Lifetime
- 1987-07-13 DE DE8787306174T patent/DE3778599D1/de not_active Expired - Lifetime
- 1987-07-14 DK DK365887A patent/DK365887D0/da not_active Application Discontinuation
1992
- 1992-04-30 GR GR920400741T patent/GR3004472T3/el unknown
1993
- 1993-04-29 SG SG55093A patent/SG55093G/en unknown
- 1993-07-15 HK HK673/93A patent/HK67393A/xx not_active IP Right Cessation
1994
- 1994-05-06 CY CY172594A patent/CY1725A/en unknown
2000
- 2000-09-06 LU LU90634C patent/LU90634I2/fr unknown
- 2000-11-03 NL NL300025C patent/NL300025I2/nl unknown

Also Published As

Publication number	Publication date
DK351887A (da)	1988-01-16
GB2192542B (en)	1990-05-02
IE871833L (en)	1988-01-15
NL300025I2 (nl)	2004-08-02
PT85305A (en)	1987-08-01
ES2033850T5 (es)	2001-07-01
LU90634I2 (fr)	2000-12-15
ZA875010B (en)	1989-02-22
JPH01500431A (ja)	1989-02-16
DK365887D0 (da)	1987-07-14
KR960001371B1 (ko)	1996-01-26
GR3004472T3 (de)	1993-03-31
AU597084B2 (en)	1990-05-24
DE3778599D1 (de)	1992-06-04
AU7537987A (en)	1988-01-21
ATE75401T1 (de)	1992-05-15
ES2033850T3 (es)	1993-04-01
WO1988000469A1 (en)	1988-01-28
PT85305B (pt)	1990-03-30
NL300025I1 (nl)	2001-01-02
HK67393A (en)	1993-07-23
SG55093G (en)	1993-07-09
EP0253607A1 (de)	1988-01-20
EP0253607B2 (de)	2001-05-23
KR880701553A (ko)	1988-11-03
JP2645510B2 (ja)	1997-08-25
GB8716431D0 (en)	1987-08-19
GB2192542A (en)	1988-01-20
DK174724B1 (da)	2003-10-06
IE61236B1 (en)	1994-10-19
EP0253607B1 (de)	1992-04-29
DK351887D0 (da)	1987-07-08
CY1725A (en)	1994-05-06

Publication	Publication Date	Title
GB2192542B (en)	1990-05-02	Combination dosage form for pre-menopausal women
EP0717626B1 (de)	2003-05-28	Zusammensetzung zur substitutionstherapie, die mindestens ein progestogen und mindestens ein oestrogen enthält
EP0911029B1 (de)	2002-04-17	Sehr niedrigdosiertes orales Kontrazeptiv mit weniger Menstruationsblutungen und verzögerter Wirkung
CA2179728A1 (en)	1995-06-29	Composition for a contraceptive comprising an estrogen and a gestagen
JPH04290828A (ja)	1992-10-15	低エストロゲン経口避妊薬
RU96115196A (ru)	1998-10-27	Состав для контрацепции
JP2000502108A (ja)	2000-02-22	ゲストゲンとエストロゲン併用によるほ乳動物の避妊法とキット
NZ333750A (en)	2000-09-29	Monophasic contraceptive method and kit comprising a combination of a progestin and estrogen
LU90341I2 (fr)	1999-03-29	75 Ug de désogestrel en l'absence éthinyl oestradiol (cerazette)
NZ333862A (en)	2000-08-25	Triphasic oral contraceptive method and kit comprising a combination of progestin and estrogen
JP2942560B2 (ja)	1999-08-30	エストロゲン欠乏症治療用組成物
WO1999025360A2 (en)	1999-05-27	Progestogen-antiprogestogen regimens
CA2311937A1 (en)	2000-04-20	Subcutaneous medroxyprogesterone acetate for treatment of menopause and endometriosis
Widholm et al.	1974	The use of conjugated oestrogen in oral contraception
Olsson	1992	Vaginal rings for contraception: endocrine parameters